Stock listing
Jasper Therapeutics, Inc.
Selected listing: JSPR · NASDAQ · USD · US
Jasper Therapeutics, Inc. (NASDAQ:JSPR), Health Technology. Latest release Sep 15, 2026: Jasper Therapeutics Announces Key Regulatory and Clinical Appointments.
- Ticker
- NASDAQ:JSPR
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc. is a public company traded under the ticker JSPR in the American market. Jasper Therapeutics focuses on developing innovative therapies in the biotechnology sector.
Latest news from Jasper Therapeutics, Inc.
Jasper Therapeutics Announces Key Regulatory and Clinical Appointments
September 15, 2026
Jasper Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 9, 2026
Jasper Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 17, 2026
Jasper Therapeutics Announces Merger with Kira Pharmaceuticals
July 16, 2026
Jasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value
May 31, 2026
Research Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc. company profile
View the public company page for Jasper Therapeutics, Inc. on 6ix.
Jasper Therapeutics, Inc. news
Read company news and market updates connected to Jasper Therapeutics, Inc..
Jasper Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Jasper Therapeutics, Inc..